Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
Conditions: Caries;   Periodontitis
Intervention: Biological: Oral hygiene with Miswak
22 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
23 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days
24 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
25 Not yet recruiting 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: Esomeprazole
26 Not yet recruiting Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
Conditions: H Pylori Infection Eradication;   Antibiotics Therapeutic Strategies;   H Pylori Eradication
Interventions: Other: Quadruple concomitant therapy treatment;   Other: Triple therapy guided by the result of the molecular resistance test
27 Recruiting Personalized Treatment for Refractory H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: rabeprazole+3 antibiotics;   Drug: rabeprazole+bismuth+2 antibiotics;   Drug: rabeprazole+amox+tetr+levo
28 Recruiting Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo+tetra;   Drug: esomeprazole+amox+levo
29 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
30 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
31 Recruiting Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Gemifloxacin-based triple therapy;   Drug: Standard triple therapy
32 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
33 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy
34 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
35 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
Intervention:
36 Not yet recruiting Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children
Conditions: Helicobacter Pylori Infection;   Iron Deficiency Anemia;   Child Development
Intervention:
37 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
38 Recruiting Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori
Condition: Helicobacter Pylori Gastrointestinal Tract Infection
Interventions: Drug: Clarithromycin;   Drug: Levofloxacin
39 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
40 Not yet recruiting Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Lymphoma;   Gastric Cancer;   Gastritis
Intervention: Other: No intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Study has passed its completion date and status has not been verified in more than two years.